Drugs / CS1
re-read 3 minutes ago

CS1

Developed for
pulmonary arterial hypertension
Investigated by
Abbott · Cereno Scientific AB · Worldwide Clinical Trials

Trials 1

PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT06321705 — pulmonary arterial hypertension Cereno Scientific AB Available No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CS1 ClinicalTrials.gov intervention name — accepted as the source's own label NCT06321705 ↗